Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company
Source: GlobeNewswireDear shareholder,
Dear Madam, Dear Sir,
please find attached our press release.
Best regards
Ackermans & van Haaren
Attachment
